AYCARDI-FONSECA ERNESTO 4
4 · Xenon Pharmaceuticals Inc. · Filed Mar 13, 2020
Insider Transaction Report
Form 4
AYCARDI-FONSECA ERNESTO
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-03-12+65,000→ 65,000 totalExercise: $11.58Exp: 2030-03-11→ Common Shares (65,000 underlying)
Footnotes (1)
- [F1]Vesting 25% on January 1, 2021 and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.